Navigation Links
Isis Pharmaceuticals to Present at Jefferies' 3rd Annual Healthcare Conference
Date:6/11/2009

CARLSBAD, Calif., June 11 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Jefferies 3rd Annual Healthcare Conference on Wednesday, June 17, 2009, at 8:00 a.m. ET in New York.

A live audio webcast of the presentation will be available on the "Investor Center" section of the Company's Web site, www.isispharm.com. A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

About Isis Pharmaceuticals, Inc.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 19 drugs in development. Isis' drug development programs are focused on treating cardiovascular, metabolic and severe neurodegenerative diseases and cancer. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics. Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide. Additional information about Isis is available at www.isispharm.com.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... The Nordic Times is a Non-commercial ... ApS, a Danish media company based in the heart ... cutting-edge news, blogs, social feeds, and original content covering ... news from around the world. , The Nordic Times ... the way that virality has changed and shaped journalism ...
(Date:9/23/2014)... Texas (PRWEB) September 23, 2014 According ... Finance Tough Mudder team just completed the Pittsburg ... obstacle course event that helps fund the wounded warrior ... Tough Mudder team member, the ”Tough Mudder is an ... obstacle course. Designed and created by British Special Forces ...
(Date:9/23/2014)... University of Cambridge has found that a common characteristic of ... ,signature, in the brain. The results are published today (23 ... The researchers studied 80 adult men with autism: 38 who ... found that language delay was associated with differences in brain ... lobe, insula, ventral basal ganglia, which were all smaller in ...
(Date:9/23/2014)... Syracuse, NY (PRWEB) September 23, 2014 Published ... suffering with mobility issues to take charge of their mobility ... to install and positively impactful. Stair lifts are that ... a home. , “Being in the elevator business, ... how to help themselves or a loved one with mobility ...
(Date:9/23/2014)... Recently, BuyTopDress.com, a popular supplier of wedding dresses and special ... fashionable marine ball dresses . Along with this, the ... brand new items; all of them are now provided with ... now, BuyTopDress.com has won more than 2000 happy customers in ... its products and after-sale services. The company is offering thousands ...
Breaking Medicine News(10 mins):Health News:Launching of The Nordic Times, a new online newspaper and aggregator. 2Health News:Presence or absence of early language delay alters anatomy of the brain in autism 2Health News:Nationwide Lifts, America’s Leader in Home Elevators, Is Proud to Announce the Release of Its First Book, “Stair Lifts: Move Up, Not Out!” 2Health News:Fashionable Marine Ball Dresses Added To BuyTopDress.com’s Collection 2
... Creates New Opportunities for Expansion of HIFU Technology, ... (USHIFU), the,distributor and provider of non-invasive high intensity ... has completed the acquisition,of Focus Surgery, Inc. (FSI) ... Sonablate(R) 500, an image-guided acoustic ablation,device. This acquisition ...
... of today,s,announcement that Attorney General Mike Cox is filing ... Coalition for a Fair and,Competitive Insurance Market is calling ... Cross Blue Shield of Michigan (BCBSM) to use their,unfair ... insurance., "We were confident when we raised this ...
... 2 A Miami resident was,sentenced to 130 months ... the,Medicare program, Acting Assistant Attorney General Matthew Friedrich of,the ... the Southern,District of Florida announced today., Gustavo Smith, ... for,the Southern District of Florida by Judge Marcia G. ...
... could one day help tailor treatments to individual patients, study ... technique for finding and analyzing stray cancer cells in the ... doctors to one day not only determine the genetic "signature" ... and adjust treatments accordingly. , "I think this is ...
... QC, July 2 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: ... a complete response to,the Food and Drug Administration ... the FDA,s Deputy Director, Center for Drug Evaluation,and ... regulatory path towards,potential U.S. approval of the Company,s ...
... July 2, 2008 -- Compact, bedside brain-activity monitors ... Washington University School of Medicine in St. Louis ... clinicians in monitoring for electrical seizures until confirmation ... an article published in the June issue of ...
Cached Medicine News:Health News:USHIFU, LLC Completes Acquisition of Focus Surgery, Inc. 2Health News:Coalition Calls on MI Legislature to Abandon Blue Cross Legislation 2Health News:Owner of Medical Equipment Company Sentenced to 130 Months in Prison for Health Care Fraud 2Health News:Owner of Medical Equipment Company Sentenced to 130 Months in Prison for Health Care Fraud 3Health News:Circulating Tumor Cells Reveal Insights Into Lung Cancers 2Health News:Circulating Tumor Cells Reveal Insights Into Lung Cancers 3Health News:Labopharm Submits Complete Response to FDA as a Result of Outcome of Appeal Process for Once-Daily Tramadol 2Health News:Seizures in newborns can be detected with small, portable brain activity monitors 2Health News:Seizures in newborns can be detected with small, portable brain activity monitors 3
(Date:9/22/2014)... BURLINGTON, Mass. , Sept. 22, 2014 Decision ... Chilean pharmaceutical market is expected to be worth $2 billion ... 11.3 percent over the next five years (to 2018). This ... growth of 4.8 percent in 2013 and 4.9 percent expected ... pharmaceutical landscape is small but highly competitive. The ...
(Date:9/22/2014)... 22, 2014 Research and Markets ... "Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, ... to their offering. On the ... technologies market has been divided into eight major ... hydrothermal, and hydromechanical ablation technologies. The light/laser ablation ...
(Date:9/22/2014)... 22, 2014  For many people experiencing issues ... facing the prospect of large, painful incisions and ... activities are also impacted, such as working, driving ... the problem, some patients even delay necessary treatment, ... lead to permanent damage for some conditions. ...
Breaking Medicine Technology:Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 2Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 3Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
Smooth, rounded working end manipulates organs less traumatically. Used as a general manipulative instrument....
This probe coagulates bleeders while suction channel with trumpet valve simultaneously evacuates smoke....
Medicine Products: